PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $523,000 | -92.1% | 4,477 | -83.9% | 0.00% | -100.0% |
| Q1 2015 | $6,579,000 | +37.9% | 27,864 | +10.5% | 0.01% | +20.0% |
| Q4 2014 | $4,770,000 | -20.3% | 25,206 | +0.5% | 0.01% | -28.6% |
| Q3 2014 | $5,986,000 | +74.2% | 25,089 | -51.8% | 0.01% | +75.0% |
| Q2 2014 | $3,437,000 | -17.0% | 52,079 | +31.0% | 0.00% | -20.0% |
| Q1 2014 | $4,141,000 | +113.1% | 39,759 | +111.9% | 0.01% | +66.7% |
| Q4 2013 | $1,943,000 | +118.1% | 18,765 | +13.0% | 0.00% | +200.0% |
| Q3 2013 | $891,000 | +1880.0% | 16,604 | +1553.8% | 0.00% | – |
| Q2 2013 | $45,000 | – | 1,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |